Cynthia Smith

CIK 1609480 · Chief Commercial Officer · last filed 2026-06-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$728.2K

Companies

7

Total Filings

43

Lifetime Open-Market Net

-$2.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TVRD Director $2.64 $0 2 2026-06-11
AGIO Director 12,414 $29.46 $365.7K $0 8 2025-08-13
SPRO Director 75,000 $2.85 $213.8K $0 9 2025-06-16
TARA Director $3.90 $0 6 2025-06-13
AKBA Director 160,933 $0.92 $148.8K -$2.5K 9 2025-06-11
Dicerna Pharmaceuticals Inc (DRNA) Delisted Director 0 $38.22 $0 $0 5 2021-12-29
ZS Pharma, Inc. (ZSPH) Delisted Chief Commercial Officer 9,155 $0 3 2015-12-10

Recent Filings · Page 2 of 5

43 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-06-10 AKBA Grant (A) +30,000 $0 EDGAR
2024-06-10 TARA Grant (A) $0 EDGAR
2024-05-30 SPRO Grant (A) +20,000 $0 EDGAR
2023-10-10 SPRO Grant (A) +20,000 $0 EDGAR
2023-08-15 AGIO Exer (M) +2,302 $0 EDGAR
2023-06-15 AGIO Grant (A) $0 EDGAR
2023-06-08 AKBA Grant (A) +30,000 $0 EDGAR
2023-06-08 TARA Grant (A) $0 EDGAR
2022-09-19 SPRO Grant (A) +15,000 $0 EDGAR
2022-08-15 AGIO Grant (A) $0 EDGAR
Showing 1120 of 43
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.